Publication | Open Access

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer

OncologyFolfox4 ChemotherapyMedicineColorectal CancerMolecular OncologyCancer TreatmentAdvanced Colorectal CancerPharmacologyRadiation OncologyPhase IbCancer Research